Drug intelligence / Profile preview

Ricorich-DHA

Development stage
Unknown
Lead developer
Oscorp Remedies
Modality
Small Molecules
Administration
Oral
01

Overview

Ricorich-DHA is a multi-ingredient nutritional supplement developed and marketed by Oscorp Remedies. It is formulated as a softgel capsule containing a combination of the carotenoid antioxidant lycopene, omega-3 fatty acids (docosahexaenoic acid and eicosapentaenoic acid), vitamins (C and E), and essential minerals (Zinc and Selenium). The supplement is designed to provide antioxidant support, promote cardiovascular health, and support cognitive function. Lycopene acts as a potent scavenger of reactive oxygen species, while DHA and EPA serve as essential structural components of cell membranes and modulate inflammatory pathways through PPAR activation. It is primarily used to address nutritional gaps and support overall metabolic and cellular health.

Brand names
Ricorich-DHARicorich + docosahexaenoic acid
Other names
Ricorich DHA
02

Targets

PPARA (Peroxisome proliferator-activated receptor alpha)PPARG (Peroxisome proliferator-activated receptor gamma)

Beyond the preview

Go deeper on Ricorich-DHA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ricorich-DHA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call